('vorinostat', 0.013389983788491988)
('COX8A', 0.013370098044378897)
('spondylocarpotarsal_synostosis_syndrome', 0.01336979181829218)
('Denosumab', 0.013359794302920417)
('CTNNB1', 0.013340120995379153)
('embryo', 0.013318414123033884)
('Fanconi_anemia_complementation_group_E', 0.013266018347240177)
('hematopoietic_cell', 0.013258388880461533)
('IL22', 0.01325417949737662)
('genistein', 0.013237637135680453)
('PTGIR', 0.013183238677313485)
('MIR214', 0.013170544341759561)
('prepulse_inhibition', 0.013144969243305616)
('CD1D', 0.013144590032250391)
('Lenalidomide', 0.01313567179617118)
('PTPN11', 0.013124754346681764)
('PSAT1', 0.013043672323774302)
('necroptotic_process', 0.013042343155847994)
('CASP3', 0.013031851507826915)
('Heparin', 0.0130144489879787)
('CXCL8', 0.013014408189481765)
('CD226', 0.013011474872293686)
('wound_healing', 0.0130047653045063)
('hepatoma_cell', 0.01297273247732523)
('TG', 0.012954299993870882)
('5-fluorouracil', 0.012937975779507992)
('NAA50', 0.01292979377891648)
('SMG1', 0.012917712109892001)
('MIR146A', 0.012907873813866825)
('THY1', 0.012884203788893408)
('tamoxifen', 0.012865563002291972)
('ATF3', 0.01285869830695288)
('NGF', 0.012847997865240985)
('platelet-derived_growth_factor_receptor_binding', 0.012836643286254786)
('CD69', 0.01281585217641625)
('DCN', 0.01280937865616517)
('BCL2L11', 0.01279411743490532)
('MAPK7', 0.012793192137112346)
('IL13', 0.012725767722719597)
('ROR1', 0.012700688943294295)
('positive_regulation_of_DNA-templated_transcription__initiation', 0.012682061230978868)
('PSMA7', 0.012677937650874513)
('Sorafenib', 0.012669482268180593)
('polyp', 0.01266815227066)
('HSPA5', 0.012664489565996024)
('culture_condition:tissue_culture', 0.012663033782084825)
('Watasenia-luciferin_2-monooxygenase_activity', 0.01265531533551231)
('NAC', 0.012654085867970047)
('Fanconi_anemia_complementation_group_B', 0.012646082732405483)
('Triptolide', 0.012637254665864989)
('cargo_receptor_ligand_activity', 0.01262290756750052)
('CDK9', 0.012587275406719766)
('TLR3', 0.0125661010248099)
('hyperglycemia', 0.01256152852993323)
('MB', 0.012553469255130154)
('IVNS1ABP', 0.01252459791961522)
('WNT5A', 0.012511615966825897)
('acute_myeloid_leukemia_cell', 0.012497197269201232)
('ATG5', 0.012461784196546552)
('fludarabine', 0.012424835017402857)
('mitochondrial_membrane', 0.012409324495793277)
('negative_regulation_of_adenylate_cyclase-activating_adrenergic_receptor_signaling_pathway', 0.012389919212581592)
('PDXP', 0.01237761829952941)
('ovary', 0.012376072959259975)
('organelle_membrane_contact_site', 0.012356498762871026)
('Chloroquine', 0.012342360567569148)
('hepatitis_B', 0.012333496929592519)
('VDR', 0.012328977620194494)
('fibroblast_growth_factor_receptor_binding', 0.012327571524161115)
('allergic_disease', 0.01232235641379669)
('DNMT3A', 0.01230757527773723)
('PRMT5', 0.012297415451193094)
('FOXO1', 0.012292756429335819)
('fibroblast_growth_factor-activated_receptor_activity', 0.01228866340494783)
